Background: Post-traumatic joint contracture (PTJC) exhibits distinctive features such as excessive collagen deposition, which is the primary cause of joint capsule fibrosis. This work aimed to examine the therapeutic impacts and the fundamental mechanisms of low-intensity pulsed ultrasound (LIPUS) on PTJC-induced fibrosis, focusing on ferroptosis-related pathways. Methods: RNA sequencing (RNA-seq) data from the Gene Expression Omnibus (GEO) database were analyzed to identify differentially expressed genes (DEGs), followed by enrichment and correlation analyses. 40 Sprague-Dawley rats were separated into 5 groups: Sham, PTJC, Natural, LIPUS, and Combined. Rats in the LIPUS and Combined groups received LIPUS stimulation, while the Combined group also received erastin injections. Hematoxylin and Eosin (H&E) staining quantified inflammatory cell infiltration; Masson’s trichrome staining measured collagen deposition. Immunofluorescence detected Cyclin D1 (fibroblast proliferation), phosphorylated nuclear factor kappa B (p-NF-κB) p65 (inflammation), solute carrier family 7 member 11 (SLC7A11)/glutathione peroxidase 4 (GPX4) (ferroptosis markers). Western blotting analyzed Collagen I/III, transforming growth factor beta 1 (TGF-β1)/Smad (fibrosis pathway). Range of motion (ROM) and joint diameter measurements evaluated contracture severity. Results: Bioinformatics analysis identified 17 ferroptosis-related and fibrosis-related target genes, with SLC7A11 and GPX4 selected for validation. ROM results indicated that LIPUS improved joint contracture more than the PTJC group, but the Combined group had less improvement than the LIPUS group alone. H&E and Masson’s Trichrome staining partially reversing PTJC-induced inflammation and collagen deposition. Mechanistically, immunofluorescence and Western blot indicated that LIPUS reduced fibrosis by decreasing the proliferation-related (Cyclin D1) and inflammation-related protein (p-NF-κB p65), and LIPUS inhibited PTJC-mediated initiation of TGF-β1/Smad signalling pathway and prevented inactivation of the SLC7A11/GPX4 axis. Erastin counteracted LIPUS effects, confirming ferroptosis involvement. Conclusions: These findings demonstrate that LIPUS significantly mitigates PTJC-induced joint capsule fibrosis by dual mechanisms: (1) activating the SLC7A11/GPX4 axis to inhibit ferroptosis and (2) suppressing TGF-β1/Smad signaling. Ferroptosis-related factors were critical as their inhibition (via erastin) exacerbated fibrosis, highlighting their role in PTJC pathogenesis.